Shares of Provention Bio soared Monday after the biopharmaceutical company agreed to be acquired by France’s Sanofi (SNY) for $25 a share, or about $2.9 billion. Provention Bio (ticker: PRVB), which f...
Tag: Healthcare/Life Sciences
First Republic, Provention Bio, Roku, Illumina, Boeing, and More Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations
Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...
This is what Warren Buffett, a self-described ‘so-so investor,’ says is his ‘secret sauce’
Stocks are rebounding on the heels of a rotten week — the worst since December for the S&P 500 SPX, +1.15% and the Nasdaq Composite COMP, +1.39%. And as Wall Street analysts go dark, with talk of ...
Nearing retirement? Here’s how to shift your portfolio from growth to income.
Over the decades, perhaps you’ve been very good at saving your money and investing it for long-term growth. But when the time comes for you to stop working or to step back to a part-time job, you migh...
Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done
An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...
China’s Newest Weapon to Nab Western Technology—Its Courts
The growing conflict between China and the U.S. extends from computer-chip factories to a suspected spy balloon over American skies. Running through it all is a struggle for technological superiority....
Here are five companies to pick if Goldman Sachs is right about the stock market being flat in 2023
Hearts, flowers and CPI data. Get ready for Tuesday. And hell hath no fury like a disappointed Wall Street. The last time CPI let the markets down — last September — stocks melted down like chocolate....
15 dividend stocks whose 5% to 10% yields appear safe in 2023 and 2024 by this analysis
Corrected dividend stock screen table, because Hanesbrands had eliminated its dividend on Feb. 2. See note above table. If you are investing in dividend stocks, the last thing you want to see is a com...
There’s still too much risk in stock and bond markets. Earn this easy 4.5% return while you wait for stability, says trader who hit 2 big calls in 2022.
Ahead of major tech earnings later, Meta results are lighting up the Nasdaq Composite COMP, +2.97% for Thursday. The S&P 500 SPX, +1.40% is also up as investors take a glass-half full view of the ...
Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.
Pfizer executives say Wall Street analysts haven’t understood just how powerful a hit the company’s Covid-19 products will take this year. That’s the explanation the company’s chief financial officer,...
Blackstone Stock Is a Good Investment, Even in a Downbeat Economy
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
China’s Big Comeback Is Just Getting Started. How to Play It.
Talk about a comeback. As China abandons policies that stifled economic growth for the past three years, investors have sent the country’s stocks soaring—up more than 50% since October. The rally migh...
Opinion: The stock market is telling you loud and clear: Now is not the time to fight the Fed or stand up to the bears.
The S&P 500 Index SPX, -1.85% hit resistance this week when an oversold rally failed near the 4080 level. This continues to support the idea that the index’s rise above 4100 in early February was ...